US Stock MarketDetailed Quotes

SLXN Silexion Therapeutics

Watchlist
  • 0.307
  • -0.013-4.18%
Close Nov 22 16:00 ET
  • 0.260
  • -0.047-15.31%
Post 20:01 ET
4.43MMarket Cap-151P/E (TTM)

Silexion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
999.32%8.04M
-2.05%1.39M
54.70%1.25M
21.27%4.68M
1.73M
731K
1.41M
808K
3.86M
Selling and administrative expenses
2,479.03%4.8M
270.91%612K
150.89%281K
60.83%928K
--465K
--186K
--165K
--112K
--577K
-General and administrative expense
2,479.03%4.8M
270.91%612K
150.89%281K
60.83%928K
--465K
--186K
--165K
--112K
--577K
Research and development costs
501.31%3.22M
-37.98%766K
41.12%961K
14.94%3.71M
--1.26M
--535K
--1.24M
--681K
--3.23M
Depreciation amortization depletion
120.00%22K
-50.00%7K
-46.67%8K
-21.05%45K
--6K
--10K
--14K
--15K
--57K
-Depreciation and amortization
120.00%22K
-50.00%7K
-46.67%8K
-21.05%45K
--6K
--10K
--14K
--15K
--57K
Operating profit
-999.32%-8.04M
2.05%-1.39M
-54.70%-1.25M
-21.27%-4.68M
-1.73M
-731K
-1.41M
-808K
-3.86M
Net non-operating interest income expense
-161,166.67%-4.84M
-87.88%4K
-50.00%19K
396.55%144K
76K
-3K
33K
38K
29K
Non-operating interest income
--0
-84.62%6K
-51.28%19K
34.21%153K
--33K
--42K
--39K
--39K
--114K
Non-operating interest expense
----
-33.33%2K
----
----
----
----
--3K
----
----
Total other finance cost
10,651.11%4.84M
----
----
-89.41%9K
---43K
--45K
--3K
--1K
--85K
Other net income (expense)
1,572.46%1.02M
78.14%-106K
-605.41%-187K
-246.87%-539K
-22K
-69K
-485K
37K
367K
Gain on sale of security
1,572.46%1.02M
78.14%-106K
-605.41%-187K
-246.87%-539K
---22K
---69K
---485K
--37K
--367K
Income before tax
-1,376.71%-11.86M
20.31%-1.49M
-93.45%-1.42M
-46.54%-5.08M
-1.67M
-803K
-1.87M
-733K
-3.46M
Income tax
-66.67%2K
-80.00%2K
-50.00%5K
33.33%32K
6K
6K
10K
10K
24K
Net income
-1,366.01%-11.86M
20.63%-1.49M
-91.52%-1.42M
-46.44%-5.11M
-1.68M
-809K
-1.88M
-743K
-3.49M
Net income continuous Operations
-1,366.01%-11.86M
20.63%-1.49M
-91.52%-1.42M
-46.44%-5.11M
---1.68M
---809K
---1.88M
---743K
---3.49M
Minority interest income
59.09%-9K
92.38%-17K
-261.29%-50K
39.19%-166K
48K
-22K
-223K
31K
-273K
Net income attributable to the parent company
-1,405.84%-11.85M
10.95%-1.47M
-77.39%-1.37M
-53.72%-4.94M
-1.73M
-787K
-1.65M
-774K
-3.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1,405.84%-11.85M
10.95%-1.47M
-77.39%-1.37M
-53.72%-4.94M
-1.73M
-787K
-1.65M
-774K
-3.22M
Basic earnings per share
-2,002.65%-2.03
10.95%-0.1806
-77.39%-0.1684
-53.72%-0.6063
-0.212
-0.0965
-0.2028
-0.095
-0.3944
Diluted earnings per share
-2,002.65%-2.03
10.95%-0.1806
-77.39%-0.1684
-53.72%-0.6063
-0.212
-0.0965
-0.2028
-0.095
-0.3944
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Total revenue 000000000
Operating revenue --0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 999.32%8.04M-2.05%1.39M54.70%1.25M21.27%4.68M1.73M731K1.41M808K3.86M
Selling and administrative expenses 2,479.03%4.8M270.91%612K150.89%281K60.83%928K--465K--186K--165K--112K--577K
-General and administrative expense 2,479.03%4.8M270.91%612K150.89%281K60.83%928K--465K--186K--165K--112K--577K
Research and development costs 501.31%3.22M-37.98%766K41.12%961K14.94%3.71M--1.26M--535K--1.24M--681K--3.23M
Depreciation amortization depletion 120.00%22K-50.00%7K-46.67%8K-21.05%45K--6K--10K--14K--15K--57K
-Depreciation and amortization 120.00%22K-50.00%7K-46.67%8K-21.05%45K--6K--10K--14K--15K--57K
Operating profit -999.32%-8.04M2.05%-1.39M-54.70%-1.25M-21.27%-4.68M-1.73M-731K-1.41M-808K-3.86M
Net non-operating interest income expense -161,166.67%-4.84M-87.88%4K-50.00%19K396.55%144K76K-3K33K38K29K
Non-operating interest income --0-84.62%6K-51.28%19K34.21%153K--33K--42K--39K--39K--114K
Non-operating interest expense -----33.33%2K------------------3K--------
Total other finance cost 10,651.11%4.84M---------89.41%9K---43K--45K--3K--1K--85K
Other net income (expense) 1,572.46%1.02M78.14%-106K-605.41%-187K-246.87%-539K-22K-69K-485K37K367K
Gain on sale of security 1,572.46%1.02M78.14%-106K-605.41%-187K-246.87%-539K---22K---69K---485K--37K--367K
Income before tax -1,376.71%-11.86M20.31%-1.49M-93.45%-1.42M-46.54%-5.08M-1.67M-803K-1.87M-733K-3.46M
Income tax -66.67%2K-80.00%2K-50.00%5K33.33%32K6K6K10K10K24K
Net income -1,366.01%-11.86M20.63%-1.49M-91.52%-1.42M-46.44%-5.11M-1.68M-809K-1.88M-743K-3.49M
Net income continuous Operations -1,366.01%-11.86M20.63%-1.49M-91.52%-1.42M-46.44%-5.11M---1.68M---809K---1.88M---743K---3.49M
Minority interest income 59.09%-9K92.38%-17K-261.29%-50K39.19%-166K48K-22K-223K31K-273K
Net income attributable to the parent company -1,405.84%-11.85M10.95%-1.47M-77.39%-1.37M-53.72%-4.94M-1.73M-787K-1.65M-774K-3.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1,405.84%-11.85M10.95%-1.47M-77.39%-1.37M-53.72%-4.94M-1.73M-787K-1.65M-774K-3.22M
Basic earnings per share -2,002.65%-2.0310.95%-0.1806-77.39%-0.1684-53.72%-0.6063-0.212-0.0965-0.2028-0.095-0.3944
Diluted earnings per share -2,002.65%-2.0310.95%-0.1806-77.39%-0.1684-53.72%-0.6063-0.212-0.0965-0.2028-0.095-0.3944
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data